Intellectual Property India Publishes Patent Application for 'Pharmaceutical Composition And Method For The Prophylaxis And Treatment Of A Lysosomal Enzyme Deficiency In A Subject With Mucopolysaccharidosis Type II' Filed by Joint-Stock Company Generium

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517089622 A) filed by Joint-Stock Company Generium, Volginskiy, Russia, on Sept. 19, for 'pharmaceutical composition and method for the prophylaxis and treatment of a lysosomal enzyme deficiency in a subject with mucopolysaccharidosis type ii.'

Inventor(s) include Shukurov, Rakhim Rakhmankulyyevich; Reshetnik, Elizaveta Vyacheslavovna; Khamitov, Ravil Avgatovich; and Shuster, Aleksandr Mikhailovich.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The invention relates to the field of biotechnology, and more particularly to a pharmaceutical co...